Palliative care in patients with primary brain tumors

Current Opinion in Oncology

Volumn 16, Issue 6, 2004, Pages 587-592

  Taillibert, Sophie ^a   Laigle Donadey, Florence ^a   Sanson, Marc ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Best supportive care; Brain tumors; Gliomas; Palliative care

Indexed keywords

ANALGESIC AGENT; ANDROGEN; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CALCIUM; CANNABINOID; CNTO 328; CYTOKINE ANTIBODY; ERYTHROPOIETIN; ETIRACETAM; GABAPENTIN; MEGESTROL ACETATE; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; STEROID; THALIDOMIDE; UNCLASSIFIED DRUG; VALPROIC ACID; VINCRISTINE; VITAMIN D;

ANEMIA; ANOREXIA; APPETITE; ARTHRALGIA; BONE NECROSIS; BRAIN TUMOR; CACHEXIA; CAREGIVER; CLINICAL TRIAL; COGNITIVE DEFECT; CRANIOTOMY; DEMENTIA; DIET; DISABILITY; DOCTOR PATIENT RELATION; EPILEPSY; EXERCISE; FAMILY; FATIGUE; GINSENG; HEADACHE; HIP DISEASE; HUMAN; INTERPERSONAL COMMUNICATION; INTRACRANIAL PRESSURE; MYALGIA; MYOPATHY; NEUROPATHIC PAIN; NEUROPATHY; NUTRITIONAL SUPPORT; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SLEEP; THROMBOEMBOLISM;

BRAIN NEOPLASMS; HUMANS; PALLIATIVE CARE; PATIENT CARE TEAM;

EID: 8344252795     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000142075.75591.02     Document Type: Review

References (45)

1. Lidstone V, Butters E, Seed PT, et al.: Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliat Med 2003, 17:588-595. This study aimed to define and prioritize the need for specialist palliative care in cancer outpatient clinics. The results of the brain tumor group are of particular interest for optimal management of these patients.
2. Daugherty CK, Steensma DP: Overcoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol 2003, 21:42s-45s. This article shows the current state of palliative care in the United States. It analyses the obstacles to hospice referral, including ethical and financial dilemmas.
3. Macedoni-Luksik M, Jereb B, Todorovski L: Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap. Pediatr Hematol Oncol 2003, 20:89-101.
4. Vecht CJ, Wagner GL, Wilms EB: Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2003, 2:404-409. This review describes the interactions between AEDs, chemotherapy, and steroids. It gives guidelines for prescribing AEDs for these patients.
5. Quevedo JF: Thromboembolism in patients with high-grade glioma. Mayo Clin Proc 1994, 69:329-332.
6. Friedman MA, Meyers C, Sawaya R: Neuropsychological effects of third ventricle tumor surgery. Neurosurgery 2003, 52:791-797.
7. de Long R, Friedman H, Friedman N, et al.: Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurol 1992, 7:462-463.
8. Klein M, Engelberts NH, van der Ploeg HM, et al.: Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 2003, 54:514-520.
9. Foladore S, Ceccherini R, Leita M, et al.: Gabapentin in chemo-induced peripheral neuropathy prevention: a phase II open study. Proc Am Soc Clin Oncol 2003, 22:768.
10. Poulson M: Not just tired. J Clin Oncol 2003, 21:112s-113s.
11. Collins A, Wang X, Saunders M, et al.: A double blind placebo controlled pilot study to evaluate the effect of ginseng on fatigue and quality of life in adult chemo-naïve cancer patients. Proc Am Soc Clin Oncol 2003, 22:733.
12. Bruera E, Driver L, Barnes E, et al.: Patient controlled methylphenidate (PCM) for cancer related fatigue (CRF): a preliminary report. Proc Am Soc Clin Oncol 2003, 22:737.
13. Tassinari D, Fochessati F, Poggi B, et al.: The costs of well-being in cancer cachexia: preliminary data of cost - utility analysis. Proc Am Soc Clin Oncol 2003, 22:775.
14. Jatoi A, Kumar S, Sloan J A, et al.: On appetite and its loss. J Clin Oncol 2003, 21:79s-81s.
15. Somerfield M: Hazards of quality-of-life data for clinical decision making. J Clin Oncol 2003, 21:82s-83s.
16. Cerny T, Lueftner D, Possinger K, et al.: Oral cannabis-extract (CE) versus delta-9-tetrahydrocannabinol (THC) for patients with cancer -related anorexia (CRA): a randomized, double-blind, placebo-controlled multicenter study. Proc Am Soc Clin Oncol 2003, 22:730.
17. von Roenn JH, Tchekmedyian S, Hoffman RM, et al.: Safety of oxandrolone in cancer-related weight loss. Proc Am Soc Clin Oncol 2003, 22:749.
18. Mahmoud FA, Walsh D, Davis M, et al.: A dose titration study of thalidomide in cancer anorexia. Proc Am Soc Clin Oncol 2003, 22:789.
19. Chang C-Y, McDonnell DP: Probing the molecular pharmacology of anabolic androgens. Proc Am Soc Clin Oncol 2003, 22:775.
20. Zaki MH, Trikha M: CNTO 328, a potent antibody to interleukin 6 inhibits human cancer cachexia in nude mice. Proc Am Soc Clin Oncol 2003, 22:174.
21. Cleeland CS, Bennett GJ, Dantzer R, et al.: Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003, 97:2919-2925. This is a report of the cytokine-immunologic hypothesis and animal model of cancer symptom expression and a discussion of further clinical approaches to these symptoms.
22. Holland JC: Psychological care of patients: psycho-oncology's contribution. J Clin Oncol 2003, 21:253s-265s. This review reports the history and evolution of psychooncology during the 25 past years.
23. Flowers A: Management of malignant gliomas at Hartford hospital: patterns of care and outcomes. Proc Am Soc Clin Oncol 2003, 22:116.
24. Efficace F, Bottomley A: Assessing HRQOL: a neglected issue for high-grade glioma. Lancet Oncol 2003, 4:11-12.
25. Manworren RCB, Hynan LS: Clinical validation of FLACC: preverbal patient pain scale. Pediatr Nurs 2003, 29:140-146.
26. Decker SA: Perry AG: The development and testing of the PATCOA to assess pain in confused older adults. Pain Manage Nurs 2003, 4:77-86.
27. Fallowfield L, Jenkins V, Farewell V, et al.: Enduring impact of communication skills training for oncologists: 12 months follow-up results of a randomised trial. Proc Am Soc Clin Oncol 2003, 22:765.
28. von Gunten CF: Discussing hospice care. J Clin Oncol 2003, 21:31s-36s. These are the recommended steps for discussing hospice care and practical guidelines for full-time oncologists. It provides practical guidelines for all-day oncologists' practice.
29. von Gunten CF: Discussing do-not-resuscitate status. J Clin Oncol 2003, 21:20s-25s. This article recommends and illustrates steps for discussing a do-not-resuscitate order. It highlights the importance of anticipating these decisions.
30. Neff P, Lyckholm L, Smith T: Truth or consequences: what to do when the patient doesn't want to know. J Clin Oncol 2003, 21:17s-19s.
31. Smith TJ: Tell it like it is. J Clin Oncol 2003, 21:12s-16s. An analysis of the communication barrier between patients and physicians, and guidelines for talking about curative treatment and palliative care.
32. Baile WF, Beale EA: Giving bad news to cancer patients: matching process and content. J Clin Oncol 2003, 21:49s-51s.
33. Himelstein BP, Jackson NL, Pegram L: The power of silence. J Clin Oncol 2003, 21:41s.
34. Gazelle G: A good death: not just an abstract concept. J Clin Oncol 2003, 21:95s-96s.
35. Harnett PR, Moynihan TJ: "But doctor, what have I have to lose?" J Clin Oncol 2003, 21:27s-29s. This is an illustration of the decision-making process involved when it is time to switch from low-yield chemotherapy to palliative care.
36. Korones DN: Taking time. J Clin Oncol 2003, 21:3366-3367.
37. Schapira L, Eisenberg PD, MacDonald N, et al.: A revisitation of "Doc, how much time do I have?" J Clin Oncol 2003, 21:8s-11s.
38. von Roenn JH, von Gunten CF: Setting goals to maintain hope. J Clin Oncol 2003, 21:570-574. This paper provides practical guidelines for improving communication between physicians and seriously ill patients, highlighting the need to use a common and well-understood language, and to set goals to maintain hope.
39. Rousseau P: Death denial. J Clin Oncol 2003, 21:52s-53s.
40. Ramondetta LM, Sills D: Spirituality and religion in the "art of dying." J Clin Oncol 2003, 21:4460-4462.
41. Breitbart W, Rosenfeld B, Pessin H, et al.: Depression, hopelessness, and desire for a hastened death in terminally ill patients with cancer. JAMA 2000, 284:2907-2911.
42. Ingham JM, Brown MD, Lawrence WF, et al.: The validity of the distress thermometer for detecting psychological distress in informal caregivers of patients with advanced cancer. Am Soc Clin Oncol Proc 2003, 22:751.
43. Gisele C, David P: Prospective cohort study of quality of care (QC) and quality of life (QL) for palliative cancer patients in three different situations: inpatient (IN), palliative care unit (PA), and home care (HO). Preliminary results. Am Soc Clin Oncol 2003, 22:791.
44. Karnad AB: House calls by oncologists: a home-visit primer. J Clin Oncol 2002, 20:3745-3746.
45. Rauch P, Muriel AC, Cassem NH: Parents with cancer: who's looking after the children? J Clin Oncol 2003, 21:117s-121s. This paper provides practical guidelines for clinicians working with parents with cancer.